IORJX | ONJAX | IORJX / ONJAX | |
Total Expense Ratio | 0.78 | 1.09 | 72% |
Annual Report Gross Expense Ratio | 0.78 | 1.09 | 72% |
Fund Existence | 6 years | 31 years | - |
Gain YTD | -2.326 | -2.572 | 90% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 278M | 278M | 100% |
Annual Yield % from dividends | 3.73 | 3.40 | 110% |
Returns for 1 year | -0.04 | -0.48 | 9% |
Returns for 3 years | 5.13 | 4.13 | 124% |
Returns for 5 years | 9.78 | 7.92 | 123% |
Returns for 10 years | N/A | 15.19 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NXP | 14.07 | 0.09 | +0.64% |
Nuveen Select Tax-Free | |||
XBAP | 36.27 | 0.17 | +0.47% |
Innovator US Eq Acltd 9 Bfr ETFTM April | |||
MEDX | 26.18 | N/A | N/A |
Horizon Kinetics Medical ETF | |||
EPRF | 17.49 | -0.05 | -0.26% |
Innovator S&P Investment Grade Prfrd ETF | |||
CGCP | 22.12 | -0.11 | -0.49% |
Capital Group Core Plus Income ETF |